6C4E.4ICD-11 MMS 2026-01
Other specified psychoactive substance withdrawal
Description
Other specified psychoactive substance withdrawal is a clinically significant cluster of symptoms, behaviours and/or physiological features, varying in degree of severity and duration, that occurs upon cessation or reduction of use of the specified substance in individuals who have developed dependence or have used the specified substance for a prolonged period or in large amounts. Other specified psychoactive substance withdrawal can also occur when prescribed psychoactive medications have been used in standard therapeutic doses. The specific features of the withdrawal state depend on the pharmacological properties of the specified substance.
Exclusions from above levels
Child codes
6C4E.40– Other specified psychoactive substance withdrawal, uncomplicated6C4E.41– Other specified psychoactive substance withdrawal, with perceptual disturbances6C4E.42– Other specified psychoactive substance withdrawal, with seizures6C4E.43– Other specified psychoactive substance withdrawal, with perceptual disturbances and seizures6C4E.4Z– Other specified psychoactive substance withdrawal, unspecified
Sibling codes
6C4E.0– Episode of harmful use of other specified psychoactive substance6C4E.1– Harmful pattern of use of other specified psychoactive substance6C4E.2– Other specified psychoactive substance dependence6C4E.3– Other specified psychoactive substance intoxication6C4E.5– Delirium induced by other specified psychoactive substance including medications6C4E.6– Psychotic disorder induced by other specified psychoactive substance6C4E.7– Certain other specified psychoactive substance-induced mental or behavioural disorders6C4E.Y– Other specified disorders due to use of other specified psychoactive substances, including medications6C4E.Z– Disorders due to use of other specified psychoactive substances, including medications, unspecified
Foundation entity
Other specified psychoactive substance withdrawal – http://id.who.int/icd/entity/2022008391
Allowed postcoordination axes
Part of: 6C4E: Disorders due to use of other specified psychoactive substances, including medications › 06: Mental, behavioural or neurodevelopmental disorders